The Infection Control Market Is Growing With High Prevalence of Infectious Diseases
The global infection control market is estimated To exhibit a CAGR of 13.3% over the forecast period, as highlighted in a new report published by Coherent Market Insights.
Infections are mainly caused by microorganisms such as bacteria, virus, and fungi or parasites. Infections can be of different types such as sexually transmitted infections, hospital acquired infections (HAIs), eye infections, skin infections, ear infections, lung & respiratory infections, and stomach and intestinal infections, among others.
𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/4126
Infection control prevents or stops the spread of infections in healthcare settings. According to the World Health Organization (WHO), infection prevention & control is a practical, evidence-based approach used to prevent health workers and patients from being harmed by avoidable infections. Infection control precautions are a set of standard recommendations used to reduce the risk of transmission of infectious agents from body fluids or environmental surfaces that contain infectious agents.
Major players operating in the global infection control market are Kimberly-Clark Corporation, Sterigenics International Inc., Matachana, Belimed AG, Sotera Health, Ecolab, Cantel Medical, Getinge AB, STERIS Corporation, Ahlstrom Corporation, Cisa S.p.A, Honeywell International Inc., MMM Group, 3M Healthcare company, Nordion Inc., Reckitt Benckiser, Synergy Health plc, Pal International, Metrex Research, Halyard Health, Sakura Global Holding Company Ltd., and Advanced Sterilization Products (Johnson & Johnson Limited), among others.
Key Market Drivers:
Increasing number of surgical procedures and high incidence of hospital-acquired infections is expected to augment the growth of the infection control market during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), hospital-acquired infections (HAIs) account for an estimated 1.7 million infections and 99,000 associated deaths each year, in American hospitals alone.
Moreover, increasing incidence of chronic diseases, growing geriatric population, and growing awareness among people about personal hygiene due to the COVID-19 outbreak is expected to augment the growth of the infection control market. For instance, according to the WHO, older people, and those with underlying medical problems such as cardiovascular disease, diabetes, and cancer are at higher risk of developing serious illness from COVID-19.
𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/4126
COVID-19 Impact Analysis:
According to the WHO, around 30 new diseases emerged in the last 20 years, and infectious diseases kill 17 million people every year. The World Health Organization (WHO) on March 11, 2020, declared the novel coronavirus (COVID-19) outbreak a global pandemic. COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Worldwide, as of 6:32pm CET, 14 February 2022, there have been 410,565,868 confirmed cases of COVID-19, with 5,810,880 deaths. Thus, there is an increasing demand for infection control. This, in turn, is expected to aid in the growth of the infection control market.
- The infection control market is expected to exhibit a CAGR of 13.3% during the forecast period due to the introduction of novel products to prevent or stop the spread of infections. For instance, in September 2021, Sodexo launched an improved, evidence-based infection prevention approach called Protecta for hospitals to fight against HAIs. This new approach will promote and support the adoption of best practices, while meeting the new National Standards of Healthcare Cleanliness.
- Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the infection control market due to the increasing prevalence of chronic diseases, high incidence of hospital-acquired infections, outbreak of COVID-19, growing geriatric population, government initiatives, and introduction of novel products in these regions. For instance, in October 2020, to fight against infectious disease, CDC launched a $ 180 million program, called Project Firstline, to help stop the spread of pathogens in healthcare settings and protect frontline healthcare workers.
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/4126
Table of Content:
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Infection Control Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Infection Control Industry Impact
Chapter 2 Global Infection Control Competition by Types, Applications, and Top Regions and Countries
2.1 Global Infection Control (Volume and Value) by Type
2.3 Global Infection Control (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Infection Control Sales, Consumption, Export, Import by Regions
Chapter 5 North America Infection Control Market Analysis
Chapter 6 East Asia Infection Control Market Analysis
Chapter 7 Europe Infection Control Market Analysis
Chapter 8 South Asia Infection Control Market Analysis
Chapter 9 Southeast Asia Infection Control Market Analysis
Chapter 10 Middle East Infection Control Market Analysis
Chapter 11 Africa Infection Control Market Analysis
Chapter 12 Oceania Infection Control Market Analysis
Chapter 13 South America Infection Control Market Analysis
Chapter 14 Company Profiles and Key Figures in Infection Control Business
Chapter 15 Global Infection Control Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027